Vildagliptin (LAF237, Novartis International AG, Basel, Switzerland), a cyanopyrrolidide-based DPP-IV inhibitor, also in late stage clinical development, has been reported to reduce fasting and postprandial glucose concentrations
Your price won't.' guarantee removes the financial anxiety of dose escalation, a common concern with stepped pricing models that raise costs at higher strengths
In August, Pfizer also started selling prescription drugs directly to consumers through PfizerForAll, which offers home delivery of prescription medicines, over-the-counter treatments, and flu and COVID-19 tests
Starting GLP-1 medications prematurely can cause increased nausea and vomiting, delayed gastric emptying, compromised nutritional intake, dehydration, and potentially delayed wound healing
Most side effects peak during the first four to eight weeks of treatment and diminish substantially thereafter
To be on the safe side, the drugs shouldnt be prescribed for high-risk individuals, like those with a personal or family history of thyroid cancer, but its not like the rats had thyroid cancer running in their families
